AMERICAN CENTURY COMPANIES INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$937,207
+73.6%
216,946
+164.8%
0.00%
Q2 2023$539,879
+313.3%
81,924
+320.9%
0.00%
Q1 2023$130,617
-61.3%
19,466
-57.4%
0.00%
Q4 2022$337,819
-11.6%
45,713
+18.1%
0.00%
Q3 2022$382,000
-38.9%
38,713
-29.9%
0.00%
Q1 2022$625,000
-27.7%
55,245
+0.3%
0.00%
-100.0%
Q4 2021$865,000
-8.4%
55,1040.0%0.00%0.0%
Q3 2021$944,000
-19.2%
55,104
+1.4%
0.00%0.0%
Q2 2021$1,169,000
+43.3%
54,3430.0%0.00%0.0%
Q1 2021$816,000
+17.6%
54,343
+3.0%
0.00%0.0%
Q4 2020$694,000
-13.7%
52,778
-36.6%
0.00%0.0%
Q3 2020$804,000
-2.3%
83,252
+15.7%
0.00%0.0%
Q2 2020$823,000
-19.2%
71,951
-26.8%
0.00%0.0%
Q1 2020$1,018,000
-19.6%
98,262
+27.4%
0.00%0.0%
Q4 2019$1,266,000
-54.7%
77,126
-63.4%
0.00%
-66.7%
Q3 2019$2,796,000
+34.2%
210,540
+86.0%
0.00%
+50.0%
Q1 2019$2,083,000
-28.9%
113,208
+1.0%
0.00%
-33.3%
Q4 2018$2,929,000
-17.9%
112,105
-27.9%
0.00%0.0%
Q3 2018$3,567,000
+211.5%
155,431
+158.6%
0.00%
+200.0%
Q2 2018$1,145,000
-25.8%
60,106
-35.2%
0.00%
-50.0%
Q3 2016$1,543,00092,7000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders